The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksColefax Grp. Regulatory News (CFX)

Share Price Information for Colefax Grp. (CFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 805.00
Bid: 770.00
Ask: 840.00
Change: 0.00 (0.00%)
Spread: 70.00 (9.091%)
Open: 805.00
High: 805.00
Low: 805.00
Prev. Close: 805.00
CFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

26 Apr 2019 07:00

RNS Number : 1710X
Colefax Group PLC
26 April 2019
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, BY ANY MEANS OR MEDIA IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

Terms not otherwise defined in this announcement shall, unless the context otherwise requires, bear the meaning given to them in the circular published by the Company and sent to Eligible Shareholders on 9 April 2019 (the "Circular").

 

 

COLEFAX GROUP PLC (the "Company")

 

Result of Tender Offer

 

Purchase of Own Shares

 

and

 

Total Voting Rights

 

 

The Company today announces the final results of the Tender Offer, details of which were set out in the Circular.

The Company confirms that the Tender Price is 550 pence, being the lower of: (i) 550 pence; and (ii) 561.75 pence, being 105 per cent. of the average closing mid-market price per Share as derived from the London Stock Exchange Daily Official List over the five Business Days immediately preceding 26 April 2019 (being the date on which the Shares are to be purchased).

The maximum aggregate number of Shares that may be purchased pursuant to the Tender Offer is 784,560 Shares (representing 8 per cent. of the Company's issued ordinary share capital).

A total of 1,171,725 Shares (representing 11.9 per cent. of the Company's issued ordinary share capital) were validly tendered by Eligible Shareholders under the Tender Offer.

All valid tenders will be satisfied in full up to the Basic Entitlement of 8 per cent., and following application of the scale-back, approximately 24.60522 per cent. of the Shares validly tendered in excess of the Basic Entitlement will also be satisfied. After application of the scale-back mechanism, a total of 784,560 Shares will therefore be purchased under the Tender Offer (representing 8 per cent. of the Company's issued ordinary share capital). The total value of all Shares purchased is £4.3 million.

Under the terms of the Repurchase Agreement, Peel Hunt has a put option exercisable on 26 April 2019 to require the Company to purchase from Peel Hunt the Shares purchased pursuant to the Tender Offer at the Tender Price. The Shares purchased by the Company pursuant to the exercise of the put option will be cancelled (the "Cancellation").

On completion of the Tender Offer and the Cancellation, the Company's issued ordinary share capital will be 9,022,440 Shares and the total number of voting rights in the Company will be 9,022,440. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure Guidance and Transparency Rules or the Market Abuse Regulation (EU) No. 596/2014.

It is expected that cheques for Tender Offer proceeds in respect of successfully tendered Shares will be dispatched and CREST payments made on 3 May 2019. Any queries concerning the calculation of accepted tenders and administration of the Tender Offer should be addressed to Computershare Investor Services PLC on +44 (0)870 889 3295.

 

As a result of the Tender Offer, there have been the following changes to the holdings of the following Directors and their connected persons:

 

Name

Number of Shares successfully tendered

Holding of Shares following the Tender Offer

% of issued Share capital following the Tender Offer

David Green

217,3021

2,501,379

27.7%

Robert Barker

20,2222

192,680

2.1%

Key Hall

12,888

148,712

1.6%

Wendy Nicholls

6,988

80,362

0.9%

 

 

 

 

 

Enquiries:

 

Colefax Group plc

 

 

David Green, Chief Executive

Rob Barker, Finance Director

020 7318 6000

Peel Hunt LLP

(Nominated Adviser and Broker)

 

Adrian Trimmings

George Sellar

Guy Pengelley

 

020 7418 8900

KTZ Communications

Katie Tzouliadis

Dan Mahoney

020 3178 6378

 

 

Important notice

Disclaimer

This announcement has been issued by and is the sole responsibility of the Company.

 

Peel Hunt LLP, which is authorised and regulated by the FCA in the United Kingdom, is acting for Colefax Group Plc in relation to the Tender Offer and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to the customers of Peel Hunt LLP nor for providing any advice in relation to the Tender Offer and/or any other matter referred to in this announcement.

 

1The Shares successfully tendered by David Green comprise 123,702 Shares in his name and 93,600 Shares in his wife's name.

2The Shares successfully tendered by Robert Barker comprise 17,695 Shares in his name and 2,527 Shares in his wife's name.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RTEEAFLSADDNEAF
Date   Source Headline
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSInterim Results
2nd Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20232:59 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM Statement
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSResult of Tender Offer
1st Sep 20237:00 amRNSTender Offer
23rd Jan 20237:00 amRNSInterim Results
20th Dec 20223:27 pmRNSHolding(s) in Company
19th Oct 20225:21 pmRNSDirector/PDMR Shareholding
5th Oct 20224:55 pmRNSHolding(s) in Company
29th Sep 20223:22 pmRNSResult of AGM
29th Sep 20222:46 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSAGM Statement
26th Sep 20223:54 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
17th Aug 20227:00 amRNSPreliminary Results
21st Apr 20227:00 amRNSTrading Update
27th Jan 20227:00 amRNSInterim Results
23rd Sep 20212:49 pmRNSResult of AGM
23rd Sep 20217:00 amRNSAGM Statement
16th Sep 20212:57 pmRNSDirector/PDMR Share Dealings
14th Sep 20217:00 amRNSResult of Tender Offer
20th Aug 20217:00 amRNSAnnouncement of Tender Offer & Posting of Circular
12th Aug 20217:00 amRNSPreliminary Results
26th Apr 202112:39 pmRNSDirector/PDMR Shareholding
16th Mar 20215:49 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amRNSInterim Results
19th Oct 20205:17 pmRNSResult of AGM
19th Oct 20207:00 amRNSAGM Statement
14th Sep 20207:00 amRNSFinal Results
23rd Mar 20207:00 amRNSCOVID-19 Impact and Interim Dividend Cancellation
25th Feb 20202:55 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSInterim Results
18th Sep 20192:14 pmRNSResult of AGM
18th Sep 20197:00 amRNSAGM Statement
23rd Jul 20197:00 amRNSPreliminary Results
7th May 20195:45 pmRNSHolding(s) in Company
1st May 20195:01 pmRNSDirector/PDMR Shareholding
30th Apr 201911:48 amRNSHolding(s) in Company
26th Apr 20197:00 amRNSResult of Tender Offer
9th Apr 20197:00 amRNSTender Offer
29th Jan 20197:00 amRNSHalf Year Results
13th Sep 20183:59 pmRNSResult of AGM
13th Sep 20187:00 amRNSAGM Statement
26th Jul 20187:00 amRNSPreliminary Results
9th Feb 20184:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.